Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multidrug resistant (MDR) bacterial infections and rare diseases in the United States. The company is headquartered in Cambridge, Massachusetts.
Click "Analyze" to generate stock analysis
SPRO Price Trend and Signals
SPRO Option Volumes & Open Interests (aggregated)
SPRO Put Call Ratios and IV (aggregated)
SPRO Financials
2025-10-23Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-21Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-21Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-21Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-21Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.